817 related articles for article (PubMed ID: 8671965)
1. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
Plum J; Mirzaian Y; Grabensee B
Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
[TBL] [Abstract][Full Text] [Related]
2. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
3. [Atrial natriuretic peptide in children with nephrotic syndrome].
Jovanovitsh O; Popovitsh-Rolovitsh M; Radoshevitsh P; Stankovitsh R; Dujitsh A; Gajitsh M; Peco-Antitsh A; Krushchitsh D; Kostitsh M
Srp Arh Celok Lek; 1995; 123(11-12):291-4. PubMed ID: 16296241
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome.
Hisanaga S; Yamamoto Y; Kida O; Kato J; Fujimoto S; Tanaka K
Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385
[TBL] [Abstract][Full Text] [Related]
5. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Burnier M; Mooser V; Wauters JP; Marder HK; De Vane P; Nussberger J; Waeber B; Brunner HR
J Cardiovasc Pharmacol; 1989 May; 13(5):682-90. PubMed ID: 2472515
[TBL] [Abstract][Full Text] [Related]
6. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
7. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
Nielsen CB; Pedersen EB
Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
[TBL] [Abstract][Full Text] [Related]
8. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
[TBL] [Abstract][Full Text] [Related]
9. Renal response to atrial natriuretic peptide in nephrotic syndrome.
Rabelink AJ; Koomans HA; Gaillard CA; Dorhout Mees EJ
Nephrol Dial Transplant; 1987; 2(6):510-4. PubMed ID: 2964567
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
12. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
13. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F
Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999
[TBL] [Abstract][Full Text] [Related]
14. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
[TBL] [Abstract][Full Text] [Related]
15. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
16. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
17. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
[TBL] [Abstract][Full Text] [Related]
18. Urinary sodium excretion in patients with nephrotic syndrome, and its circadian variation.
Koopman MG; Koomen GC; van Acker BA; Arisz L
Q J Med; 1994 Feb; 87(2):109-17. PubMed ID: 8153287
[TBL] [Abstract][Full Text] [Related]
19. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide.
Trevisani F; Colantoni A; Sica G; Gasbarrini A; D'Intino PE; De Notariis S; De Jaso R; Barbieri A; Morselli A; Gasbarrini G
Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404
[TBL] [Abstract][Full Text] [Related]
20. Effects of uroguanylin on natriuresis in experimental nephrotic rats.
Baba A; Fujimoto S; Kikuchi M; Kita T; Kitamura K
Nephrology (Carlton); 2009 Feb; 14(1):80-5. PubMed ID: 19054333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
